» Articles » PMID: 32099946

Portal Venous Metabolite Profiling After RYGB in Male Rats Highlights Changes in Gut-Liver Axis

Overview
Journal J Endocr Soc
Specialty Endocrinology
Date 2020 Feb 27
PMID 32099946
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

After Roux-en-Y gastric bypass (RYGB) surgery, the intestine undergoes structural and metabolic reprogramming and appears to enhance use of energetic fuels including glucose and amino acids (AAs), changes that may be related to the surgery's remarkable metabolic effects. Consistently, RYGB alters serum levels of AAs and other metabolites, perhaps reflecting mechanisms for metabolic improvement. To home in on the intestinal contribution, we performed metabolomic profiling in portal venous (PV) blood from lean, Long Evans rats after RYGB vs sham surgery. We found that one-carbon metabolism (OCM), nitrogen metabolism, and arginine and proline metabolism were significantly enriched in PV blood. Nitrogen, OCM, and sphingolipid metabolism as well as ubiquinone biosynthesis were also overrepresented among metabolites uniquely affected in PV vs peripheral blood in RYGB-operated but not sham-operated animals. Peripheral blood demonstrated changes in AA metabolism, OCM, sphingolipid metabolism, and glycerophospholipid metabolism. Despite enrichment for many of the same pathways, the overall metabolite fingerprint of the 2 compartments did not correlate, highlighting a unique role for PV metabolomic profiling as a window into gut metabolism. AA metabolism and OCM were enriched in peripheral blood both from humans and lean rats after RYGB, demonstrating that these conserved pathways might represent mechanisms for clinical improvement elicited by the surgery in patients. Together, our data provide novel insight into RYGB's effects on the gut-liver axis and highlight a role for OCM as a key metabolic pathway affected by RYGB.

Citing Articles

Gut Microbiota and Sinusoidal Vasoregulation in MASLD: A Portal Perspective.

Baffy G, Portincasa P Metabolites. 2024; 14(6).

PMID: 38921459 PMC: 11205793. DOI: 10.3390/metabo14060324.


Differential effects of bariatric surgery and caloric restriction on hepatic one-carbon and fatty acid metabolism.

Haran A, Bergel M, Kleiman D, Hefetz L, Israeli H, Weksler-Zangen S iScience. 2023; 26(7):107046.

PMID: 37389181 PMC: 10300224. DOI: 10.1016/j.isci.2023.107046.


Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia.

Sandoval D, Patti M Nat Rev Endocrinol. 2022; 19(3):164-176.

PMID: 36289368 PMC: 10805109. DOI: 10.1038/s41574-022-00757-5.


Regulation of body weight: Lessons learned from bariatric surgery.

Albaugh V, He Y, Munzberg H, Morrison C, Yu S, Berthoud H Mol Metab. 2022; 68():101517.

PMID: 35644477 PMC: 9938317. DOI: 10.1016/j.molmet.2022.101517.

References
1.
Cavin J, Couvelard A, Lebtahi R, Ducroc R, Arapis K, Voitellier E . Differences in Alimentary Glucose Absorption and Intestinal Disposal of Blood Glucose After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy. Gastroenterology. 2015; 150(2):454-64.e9. DOI: 10.1053/j.gastro.2015.10.009. View

2.
Magkos F, Bradley D, Schweitzer G, Finck B, Eagon J, Ilkayeva O . Effect of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding on branched-chain amino acid metabolism. Diabetes. 2013; 62(8):2757-61. PMC: 3717831. DOI: 10.2337/db13-0185. View

3.
Mutch D, Fuhrmann J, Rein D, Wiemer J, Bouillot J, Poitou C . Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery. PLoS One. 2009; 4(11):e7905. PMC: 2775672. DOI: 10.1371/journal.pone.0007905. View

4.
Pardina E, Ferrer R, Rossell J, Ricart-Jane D, Mendez-Lara K, Baena-Fustegueras J . Hepatic CD36 downregulation parallels steatosis improvement in morbidly obese undergoing bariatric surgery. Int J Obes (Lond). 2017; 41(9):1388-1393. DOI: 10.1038/ijo.2017.115. View

5.
Immonen H, Hannukainen J, Iozzo P, Soinio M, Salminen P, Saunavaara V . Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients. J Hepatol. 2013; 60(2):377-83. DOI: 10.1016/j.jhep.2013.09.012. View